Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Rezatomidine

Copy Product Info
😃Good
Catalog No. T34308Cas No. 847829-38-3
Alias AGN-203818, AGN203818, AGN 203818

Rezatomidine (AGN203818) is a selective antagonist of α2-adrenergic receptor and can be used in studies about chronic pain, including neuropathic pain.

Rezatomidine

Rezatomidine

Copy Product Info
😃Good
Purity: 98.34%
Catalog No. T34308Alias AGN-203818, AGN203818, AGN 203818Cas No. 847829-38-3
Rezatomidine (AGN203818) is a selective antagonist of α2-adrenergic receptor and can be used in studies about chronic pain, including neuropathic pain.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$195In StockIn Stock
2 mg$293In StockIn Stock
5 mg$448In StockIn Stock
10 mg$658In StockIn Stock
25 mg$987In StockIn Stock
50 mg$1,380In StockIn Stock
100 mg$1,890-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:98.34%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Rezatomidine AI Summary
Rezatomidine shows moderate to high plasma protein binding affinity, with approximately 81.01% to 83.04% bound to rat and human plasma. It exhibits moderate intrinsic clearance in human liver microsomes and rat hepatocytes, with clearance rates of 24.55 mL·min^-1·g^-1 and 25.7 µL·min^-1·(10^6 cells)^-1, respectively. Additionally, the compound has a favorable distribution coefficient in the octan-1-ol/water (pH 7.4) system, with a LogD7.4 value of 2.9. In pharmacological studies, Rezatomidine shows a reduction in sulphrostone-induced tactile hypersensitivity in C57BL/6 mice when administered orally or intraperitoneally at 1 µg/kg, with an activity of 50.0%. It also induces sedation in the same mice when administered orally at higher doses of 100 to 1000 µg/kg, with an activity of less than 30.0%..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Rezatomidine (AGN203818) is a selective antagonist of α2-adrenergic receptor and can be used in studies about chronic pain, including neuropathic pain.
SynonymsAGN-203818, AGN203818, AGN 203818
Chemical Properties
Molecular Weight232.34
FormulaC13H16N2S
Cas No.847829-38-3
Smiles[C@H](C)(C1=C(C)C(C)=CC=C1)C2=CNC(=S)N2
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 2 mg/mL (8.61 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM4.3040 mL21.5202 mL43.0404 mL215.2019 mL
5 mM0.8608 mL4.3040 mL8.6081 mL43.0404 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Rezatomidine | purchase Rezatomidine | Rezatomidine cost | order Rezatomidine | Rezatomidine chemical structure | Rezatomidine formula | Rezatomidine molecular weight